October 2026 Benchmarking Report: What Dental Practices Are Selling For Heading Into Q4
A single-location general practice collecting $1.6 million can be worth $1.69 million or $2.57 million heading into Q4 2026, and the $875,000 spread has almost nothing to do with which broker you hire or how many letters of intent you stack up. It has to do with one number on one line of a recast profit and loss statement, and most owners have that number wrong by six figures in their own favor.
Here is our position, and plenty of transition advisors will argue with it: if your adjusted EBITDA is under roughly $400,000, the multiple is not something you negotiate, it's something you qualify for. Buyers in that band are running a formula, not a bidding war. The competitive process you're being sold will move your price by a rounding error compared to what eighteen months of disciplined overhead work would have done. We'd spend the money on the practice, not the process.
The 2026 Multiple Ladder Is Really an EBITDA Ladder
The published ranges for this year are wide and they're wide for a reason. DSO acquisition multiples in 2026 run from about 5x adjusted EBITDA for small single-location add-ons up to 10x to 12x and beyond for platform-grade practices with $5 million or more in EBITDA, with specialty practices commanding one to three additional turns.
Read that again as an operator rather than a seller. The multiple isn't a market condition applied evenly across all sellers in a given quarter. It's a function of what you are to the buyer. A $300,000-EBITDA general practice is inventory. It gets folded into an existing region, its overhead gets squeezed by someone else's supply contract, and the acquirer's underwriting model has a ceiling on what it will pay for that kind of asset no matter how good the relationship feels in the conference room.
The practices that get 10x are not better dentistry. They're bigger, more diversified, and already structured to run without the seller. That's why the top of the range is gated at $5 million in EBITDA. At that size you're not an add-on, you're a platform, and the buyer is underwriting their own exit at a higher multiple two or three years out. They can afford to pay 10x because they intend to sell at 14x.
So the practical question for a solo owner in October 2026 is not "what are multiples doing." It's "which rung of the ladder am I standing on, and can I climb one before I sign." For most readers of this publication the honest answer is that you're on the bottom rung and you have more room to move than you think, but the room is in the numerator, not the multiplier.